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Abstract: Though the guidelines for the optimal management of chronic obstructive pulmonary 
disease (COPD) following an acute exacerbation (AE) are well established, issues associated 
with poor adherence to nonpharmacological interventions such as self-management advice 
and pulmonary rehabilitation will impact on hospital readmission rates and health care costs. 
Systems developed for clinically stable patients with COPD may not be sufficient for those 
who are post-exacerbation. A redesign of the manner in which such interventions are deliv-
ered to patients following an AECOPD is necessary. Addressing two or more components of 
the chronic care model is effective in reducing health care utilization in patients with COPD, 
with self-management support contributing a key role. By refining self-management support 
to incorporate the identification and treatment of psychological symptoms and by providing 
health care professionals adequate time and training to deliver respiratory-specific advice and 
self-management strategies, adherence to nonpharmacological therapies following an AE may 
be enhanced. Furthermore, following up patients in their own homes allows for the tailoring of 
advice and for the delivery of consistent health care messages which may enable knowledge to 
be retained. By refining the delivery of nonpharmacological therapies following an AECOPD 
according to components of the chronic care model, adherence may be improved, resulting in 
better disease management and possibly reducing health care utilization.
Keywords: acute exacerbation, chronic obstructive pulmonary disease, pulmonary rehabilita-
tion, self-management, physical activity, oxygen, adherence, chronic care model
Introduction
Currently the fourth leading cause of death worldwide, and soon to become the third,1,2 
chronic obstructive pulmonary disease (COPD) is a pernicious disease characterized 
by progressive decline punctuated with acute exacerbations (AEs).
An AECOPD is defined by a sustained worsening of symptoms, beyond normal 
day-to-day variation, which requires medical treatment.3 Its presence poses a signifi-
cant burden for the patient in terms of increased anxiety and depression,4,5 decreased 
health-related quality of life (HRQOL),6 and decreased physical activity (PA),7–9 as 
well as on the health care system resources. A large proportion of COPD-related costs 
can be attributed to hospital admissions and readmission, with 34% of the patients 
discharged from hospital following an AE being readmitted within a 3-month period 
for symptoms pertaining to an AE.10 Annual costs to the US economy currently exceed 
US$49.5 billion11 and €38.6 billion in Europe.12 Costs are likely to inflate as the preva-
lence of COPD continues to rise largely due to an increasing incidence in women and 
an aging population.13 Certainly, a comprehensive, flexible, and long-sighted plan is 
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required to tackle the many complex issues surrounding the 
management of this episodic chronic disease.
Guidelines for the optimal management of COPD fol-
lowing an AE are now well established1,14 and include both 
pharmacological (ie, inhalers, steroids) and nonpharmaco-
logical interventions such as self-management advice and 
pulmonary rehabilitation (PR). Despite medical management, 
patients often experience recurring symptoms following an 
AE serious enough to result in a readmission to the hospital.10 
Nonpharmacological therapies delivered following an AE15 
and in patients whose COPD is stable16 have shown a reduc-
tion in hospital admissions. However, there are often issues 
surrounding patient adherence to such interventions includ-
ing access,17 referral procedures,18 health care professionals’ 
(HCPs) resources and knowledge,19 patient activation, and 
willingness to engage in therapy.20
In this paper, the chronic care model (CCM) will be 
used as a framework to address issues of poor adherence to 
nonpharmacological interventions following an AECOPD. 
The CCM was first introduced by Wagner et al and aims to 
“[identify] the essential elements of a health care system 
that encourage high-quality chronic disease care” through a 
working framework of common-sense components.21 These 
include health system-to-community linkages (planning, 
partnerships, and goals), self-management support (emphasis 
on the central role of the patient through education, skills 
training, and psychological support), delivery system design 
(focus on teamwork, clearly defined roles, and sustained 
follow-up), decision support (integration of evidence-based 
guidelines into daily clinical practice), and clinical informa-
tion systems (development of relevant client data to identify 
subgroups with special needs).
The model nurtures productive relationships between 
experienced HCPs (nurses, physicians, physiotherapists, 
pharmacists, etc) and informed patients who actively par-
ticipate in their ongoing disease management, resulting in a 
broadly applicable, higher quality patient care environment. 
The goal of the CCM is to create activated and empowered 
patients and prepared and proactive HCPs, promote cost sav-
ings, and improve clinical and functional outcomes.
The CCM has been used in the development of successful 
disease-specific protocols for conditions such as diabetes mel-
litus, asthma, depression, and congestive cardiac failure,22,23 as 
well as care after acute events such as a myocardial infarction.24 
Importantly, the CCM model has been applied in COPD, and 
the use of interventions with two or more CCM components 
has been shown to reduce inpatient admissions and emergency 
department visits for patients in whom COPD is stable.25
A recent review by Fromer has recommended the imple-
mentation of primary care workflows for patients with COPD, 
which may impact on early detection and treatment of AE, 
perhaps reducing health care utilization.26 In their discussion, 
the authors used CCM as an outline for practical evidence-
based recommendations such as “devising a COPD care 
workflow that implements essential tasks of risk awareness, 
spirometric diagnosis, guideline-based treatment and reha-
bilitation, and equipping patients for self-management”. This 
review article will build on the work of Fromer by providing 
recommendations for nonpharmacological management fol-
lowing an AECOPD.
Specifically, the review will address PR, PA, and self-
management strategies, and the use of therapeutic aids such 
as rollators and supplemental oxygen therapy. Based on the 
evidence, recommendations will be formulated to optimize 
nonpharmacological care following an AECOPD.
Pulmonary rehabilitation
PR is central to the management of patients with COPD, 
and its recommendation has been documented in both 
national and international guidelines.27–29 Comprehensive 
PR programs involve a patient assessment and an interven-
tion delivered by a multidisciplinary team over 6–12 weeks, 
with at least two sessions per week of supervised exercise 
and education.30 Although the majority of programs are 
delivered in hospital outpatient settings, PR is available in 
various locations including hospital inpatient, community, 
and home settings.27–29
As well as improving exercise tolerance, PR has been 
shown to be effective in reducing breathlessness, increas-
ing HRQOL, and improving symptoms of anxiety and 
depression.30,31 The benefits of PR in patients with stable 
COPD have led to its expansion for patients following an AE, 
with those completing it having fewer hospital readmissions 
and significantly less likelihood of experiencing reoccurring 
symptoms, as well as benefiting in terms of improved func-
tional capacity and health status.15
Despite the flexibility in delivery, access to PR is still very 
limited. An international review of PR programs indicates 
that #1.2% of individuals with COPD have current access to 
PR services.17 These recent results reflect the findings from 
10 years earlier when the availability of PR services was 
quoted as #1.2% in Canada and #1.5% in the UK.32,33 It 
is particularly surprising and somewhat disappointing that, 
despite the vast growth in evidence supporting the effec-
tiveness of PR, in the past decade access to services has 
not improved. Furthermore, it is likely that access to PR is 
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even more limited in the underdeveloped countries, but to 
date service provision has only been explored in affluent 
countries.17
Limited access to PR services may, in part, be assigned 
to the cost of delivering the intervention. The National 
Emphysema Treatment Trial (NETT) estimated that PR 
costs US$2,200 per patient.34 However, as PR translates into 
reduced health care utilization, particularly in relation to 
readmissions post-exacerbation,15 it is reasonable to assume 
that underutilization of PR may ultimately lead to increased 
health care spending.
Even when PR services are available, the number of 
patients being referred is not always optimal. A prospective 
audit found that, despite a fully commissioned PR service, 
only 32% of all patients eligible for post-AE PR were in fact 
referred.18 The primary reasons for HCPs not complying with 
the recommended guidelines for COPD management have 
been cited as poor self-efficacy, decreased familiarly with 
the guidelines, and time.19 Alternative explanations may 
include not being aware of the correct referral procedures 
for PR diffusion of responsibility (eg, HCPs do not ensure 
that the topic of PR is discussed), or a referral is made but 
is not documented or followed up.
Although there is interest in increasing the referral rate of 
patients to PR following hospitalization with an AECOPD, if 
patients are unable or unwilling to attend PR, increasing the 
number of referrals will not impact on the number of patients 
completing the program. In a recent prospective observational 
study, 128 patients were referred to post-AE PR and yet only 
30% attended their initial assessment.20 The percentage of 
patients quoted in this study as completing PR (9%) is the 
same as the figure quoted by Jones et al, patients being lost 
at the time of referral, at the initial assessment, and following 
enrollment in PR.18,20 Therefore, simply increasing referral 
rates is not enough to enhance the number of patients who 
complete PR programs following an AE.
Originally developed for patients in whom COPD is 
stable, PR may not meet the additional needs of the post-
exacerbation patient. Poor attrition to post-exacerbation 
PR may be a reflection of the intense emotional distress 
reported by patients35 in whom increased anxiety has been 
observed.36
Feelings of distress provide the focus of cognitive behav-
ioral therapy (CBT). However, the appropriateness of solely 
CBT and its effectiveness in reducing feelings of anxiety in 
patients with COPD are still unclear.37 A stepped-care approach 
has been applied to treating the psychological needs of 
patients post-myocardial infarction. A range of psychological 
 treatments were offered, including education, a brief behavioral 
intervention, and individual CBT. Out of 125 patients, only 
23 required the most intense intervention (individual CBT) 
and yet the overall symptoms of anxiety and depression were 
reduced by 19% and 13.5%,  respectively.38 The observation that 
a stepped-care approach can reduce psychological symptoms 
in patients with chronic disease following an acute event may 
have applicability to the post-AE population.
Physical activity
Engaging in at least 30 minutes of moderate PA a day 
has been advocated for older adults.39 PA is substantially 
reduced in individuals with COPD compared to healthy 
older adults40 and those with chronic conditions, such as 
heart failure and arthritis.41 In COPD, low PA is associated 
with an increased risk of hospitalizations, reduced exercise 
capacity, and increased mortality.7,9,42 PA is a strong predic-
tor of all-cause mortality in COPD,43 and is detrimentally 
affected by the inactivity associated with one or more hospital 
admissions.7
Following hospitalization for an AECOPD, patients report 
numerous barriers to PA, which can be categorized as external 
(weather, transport, and finances) and internal (symptoms 
and comorbidities).44 Most notably, patients report former 
experiences with PA as a barrier, citing negative experi-
ences relating to exercise intensity and irregular follow-ups 
as deterrents to further PA.45 Enablers of PA are less readily 
acknowledged, although social support has been identified as 
an important facilitator for leaving the house.44 Patients also 
note that the watchful protection of family members may be 
a barrier to PA and greater independence.45
Support from HCPs to set goals and encourage motiva-
tion appears to be an important factor in incorporating PA in 
post-AE care.44 However, encouraging PA that is associated 
with feelings of breathlessness is likely to be challenging.35 
HCPs cite reduced self-efficacy and a lack of time as barriers 
to implementing COPD guidelines,19 hindered by the focus 
of the health care system on reducing length of stay, with 
discharge criteria centered on medical stability.
PA appears to spontaneously recover following an AE, 
but it fails to reach pre-AE levels.7,46 Recent systematic 
review findings indicate small, but favorable increases in 
PA following PR, with further support required to facilitate 
greater change.47 This support is best provided by practitio-
ners who are competent in behavioral techniques.47 Motiva-
tional interviewing has been shown to promote behavioral 
change,48 with telephone-based interventions resulting in 
increased self-efficacy and short-term PA in older adults.49
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Self-management
Self-management interventions play a key role in the conti-
nuity and coordination of care for patients with COPD. The 
term “self-management” describes “A formulized patient 
education program that aims to teach the necessary skills 
and carry out specific medical regimes and guide health 
behavior change for patients to control their disease and 
improve  well-being.”50 Self-management interventions have 
been defined as consisting of action plans, education, and 
two or more self-management skills including self-efficacy, 
problem solving, resource utilization, collaboration, emo-
tional management, role management, and goal setting.51 
An admission to hospital with an AE is considered to be 
an indicator of the patient’s failure to manage the disease, 
emphasizing the role of a self-management intervention at 
this critical time. Hospitalization provides an opportunity 
for HCPs to offer self-management advice, and patients 
may be more motivated to change their behavior at a time 
of perceived vulnerability.
However, the effectiveness of self-management inter-
ventions, delivered in their current form, for patients 
post-AECOPD has been the subject of debate. Although 
some studies have found self-management to be a success-
ful strategy for reducing hospital admissions in patients 
with COPD52–55 by improving management of AEs,56,57 
others describe results as largely equivocal58,59 one large, 
randomized, controlled trial actually showed increased 
mortality in those patients undertaking a self-management 
intervention.60 In a recently updated Cochrane review, self-
management was delivered to patients with stable disease or 
those up to 12 months post-AE.16 Only one study delivered 
 self-management to all patients immediately following an 
AECOPD and found the intervention to be effective in reduc-
ing hospital admissions.61
The success of post-AE self-management interventions 
may be affected by patients’ inability or unwillingness to heed 
to the information being provided. During an AE, feelings 
of distress associated with the sensation of breathlessness 
and the threat of dying are prominent.62 Heightened levels 
of anxiety and vigilance of breathless symptoms may serve 
to distract patients’ attention from the information being 
delivered.35
Adherence to health-promoting behavior has been 
associated with patients’ beliefs regarding the efficacy of 
treatment.63,64 Beliefs are formed through the process of 
self-regulation65 whereby patients reflect on their previ-
ous  experiences and also deliberate information gleaned 
from external sources such as HCPs and peers. However, 
 self-regulation may be hampered by impaired cognitive 
 processing sometimes present in older adults with COPD, 
which may compromise their ability to deliberate on the 
information.66,67 Self-management skills appear to be more 
readily mastered by a younger COPD population,58 which 
suggests that greater input to enhance learning and knowledge 
acquisition may be required in the older population.
Although in recent years there has been a shift of the 
health care system away from a paternalistic model, this 
model of care is still preferred by some older adults68 and 
a view of doctors as authoritative figures legitimizes help-
seeking which may pose a barrier for self-management 
behavior. On the other hand, narratives reflecting stoicism 
and independence are common in patients with COPD.69 
Following an AE, where feelings of control are likely to be 
diminished, patients are eager to manage the disease and 
may view external support as threatening their integrity, 
perhaps explaining the high rates of noncompliance to self-
management interventions.70,71 To promote engagement, 
HCPs must form therapeutic alliance with patients.
The most successful interventions at reducing hospital 
readmissions and improving HRQOL encompass specific 
self-management skills such as problem solving and goal 
setting.59,61 Although in research studies self-management 
interventions are delivered by specialist HCPs or those who 
have received specific training,58,71,72 in reality this is often 
not the case.
It has recently been suggested that self-management 
interventions that focus on “embracing patients’ values” 
and “igniting inner motivation” may be the most successful. 
A qualitative investigation into motivational interviewing 
noted that patients valued supportive communication with an 
HCP and emphasized the importance of partnership working 
in promoting engagement.73 A self-management intervention 
delivered in combination with motivational interviewing 
strategies has shown promising results at increasing patient 
adherence and improving HRQOL in patients with severe 
COPD.74
Rollators
Rollators provide a nonpharmacologic approach to the relief 
of exertional dyspnea by providing mechanical assistance 
during walking. They can be frequently prescribed tempo-
rarily following an AECOPD when heightened symptoms 
of breathlessness limit PA. They can also be prescribed for 
long-term use in response to disease progression. There are 
a variety of mechanisms by which the rollator may assist 
walking, including repositioning the body forward to an 
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improved biomechanical position, stabilizing the arms and 
upper ribcage to enable the respiratory muscles to make 
greater contributions to breathing, moving some of the 
patient’s weight to the rollator, and improving pacing and 
walking efficiency.75 In a population of frail, elderly COPD 
patients, balance control is likely to be compromised76,77 and 
a rollator may be a useful device in limiting falls. Despite 
the popularity of rollators and the costs associated with 
these devices,78 their daily utility and user satisfaction vary 
among patients.
In individuals with COPD, with unassisted 6-minute walk 
distance of less than 300 m, rollators resulted in an increase 
in walking distance and a decrease in dyspnea during a walk 
test.75 Notwithstanding this immediate improvement, Gupta 
et al have reported that 44% of subjects did not use them 
at least three times per week. Understandably, those who 
reported frequent use improved their exercise capacity and 
HRQOL.79 In an attempt to explore this, Hill et al character-
ized the daily utility and satisfaction with rollators in patients 
with COPD who had been provided with one within the 
 preceding 5-year period.78 Just over half of the patients (59%) 
reported daily rollator use, mainly for walking outdoors. 
Although satisfaction with the rollator was high, almost half 
of the patients reported being embarrassed while using the 
device, stating that, “it is a visual indication of your handicap 
and age” and that “people judge and pity you”.
Home oxygen
Two randomized trials conducted in the 1980s and a Cochrane 
review established the positive effect of oxygen, including 
improved survival in those that have a resting room air 
PaO
2
 #55 mmHg. 80–82 In individuals with COPD who do not 
meet this “life-prolonging” criterion but become hypoxemic 
only during exertion or during sleep, there is no convinc-
ing positive effect of oxygen.83,84 Oxygen during transient 
exercise hypoxemia does increase exercise measured under 
laboratory circumstances85 and has been used successfully 
during exercise training,86 but it has not been shown to 
be useful when provided at home to assist with dyspnea 
management.85,87 Although oxygen is often used clinically 
in hospital and at home, post-AE there is little objective 
evidence of its impacting morbidity or mortality.
Nonadherence to oxygen therapy has been frequently 
described87–89 and has been associated with several clinical, 
respiratory, cognitive, and social factors.90 Upon  discharge 
from the hospital, patients report uncertainty regarding the 
provision and use of oxygen.91 Although patients recognize 
its benefits for social involvement and physical activities, 
they also express concerns regarding dependency, social 
restriction, the use of equipment, stigma, lack of sufficient 
information, and uncertainty about the benefits.92
Approaches that may enhance adherence to oxygen 
therapy include regular follow-up, ongoing communication 
between the prescribing HCP and the patient, education with 
both verbal and written information, training of the family 
and social support, as well as carefully matching the equip-
ment to the needs of the patient.93
Discussion
This review has outlined some nonpharmacological thera-
pies that may be applicable following an AECOPD. The 
CCM is a useful framework from which to consider issues 
of nonadherence to these approaches. The application of 
two or more components of the CCM (health system-to-
community linkages, self-management support, delivery 
system design, decision support, and clinical information 
systems) has been shown to be effective in reducing health 
care utilization.25 Informed by the content of this review, the 
following recommendations focus on two components of 
the CCM and are centered on addressing those issues that 
consistently arise when describing nonadherence to nonphar-
macological approaches post-AECOPD: 1) self-management 
support, emphasizing the central role of the patients through 
education, skills training, and psychological support, and 
2) delivery system design, focusing on teamwork, clearly 
defined roles, and sustained follow-up.
Self-management support: psychological 
support
Recommendation 1
Patients’ psychological status needs to be routinely assessed 
and addressed following an AECOPD.
AEs have a profound emotional impact on patients with 
COPD, and therefore psychological assessment should be 
routinely conducted as part of patient management. Although 
symptoms of anxiety and depression are common in patients 
with COPD,94 patients rarely present with psychological 
symptoms severe enough to warrant a clinical diagnosis. 
Perhaps, psychological assessment should consider going 
beyond the biomedical indices of anxiety and depression 
(ie, Hospital Anxiety and Depression Scale) and focus on a 
fine-grained assessment of psychological disturbance salient 
to the disease population. Patients’ narratives reflect feelings 
of embarrassment, shame, and concern about stigma when 
describing the use of visible therapeutic aids such as oxygen 
and rollators, and such self-conscious emotions have also 
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been documented in a population of patients’ who decline 
PR following an AECOPD.69
Mindfulness is one intervention that aims to reduce the neg-
ative emotions associated with feelings of self- consciousness. 
Often delivered in conjunction with  compassion-focused 
therapies, mindfulness encourages patients to accept their 
feelings in a nonjudgmental way by disengaging from the 
content of distressing thoughts and focusing on goal-based 
actions. Promising results for the application of mindfulness 
in a COPD population are offered by a recent qualitative 
investigation which outlines positive effects on the adoption 
of healthy behaviors, even after 1 year.73
There has been growing interest in the development of 
interventions guided by the manner in which patients perceive 
their illness.95 Lack of control and high emotional distress 
are important following an AECOPD.20 In contrast, a high 
sense of control and a view of illness as serious have been 
noted to be influential in promoting adherence to positive 
health behaviors in patients with diabetes and following a 
myocardial infarction.96,97 An intervention designed to shape 
patients’ illness perceptions was found to be effective in 
improving adherence to a cardiac rehabilitation program by 
20%.98 Therefore, a similar type of intervention may be of 
value in promoting adherence to PR.
Self-management support: education  
and skills training
Recommendation 2
HCPs require more training regarding the delivery of self-
management skills and need to be afforded adequate time in 
order to deliver this information effectively.
The timely discharge of patients from hospital following 
an AECOPD is often encouraged to promote cost saving. 
However, at a time of vulnerability, patients are sensitive 
to the perceived dismissive nature of HCPs.45,62,99 Early 
discharge, often with little support, may not be considered 
conducive to promoting feelings of safety and trust that are 
necessary for acceptance of recommended health behaviors, 
such as increased PA and attendance to PR. HCPs need to be 
given adequate time to deliver complex interventions during 
a period when patients are acutely unwell.
Reduced self-efficacy in implementing COPD guidelines is 
cited by HCPs to deliver COPD-specific education and teach 
self-management skills.19 Therefore, additional training is 
required to ensure that HCPs are confident of delivering self-
management strategies that are conducive to behavior change.
Motivational interviewing is an example of a stepped-care 
approach which appears to be useful in eliciting behavior 
change. However, if not delivered correctly, it is unlikely 
to be successful. The trans-theoretical model assesses 
readiness to change by considering various stages of change 
demonstrated by individuals.100 It is important that HCPs 
have knowledge of this theory and receive training in order 
to assess at which stage the patient is currently in. This will 
allow strategies to be tailored accordingly: for example, 
advising actions for a patient in the precontemplation 
stage will not result in behavior change; instead, exploring 
 barriers and instilling hope may be more effective.101 A key 
component of motivational interviewing is partnership 
working. Allowing patients to maintain control over their 
disease management rather than handing management of 
their disease over to others (ie, HCPs) appears particularly 
important following an AECOPD when feelings of control 
have been threatened.
Delivery system design: sustained follow-up
Recommendation 3
Post-AE is an opportune time to implement interventions, 
but follow-up is necessary to reinforce information.
Following hospitalization with an AECOPD, patients may 
be more receptive to interventions that are likely to improve 
their health, providing an opportune time for HCPs to intro-
duce disease-management strategies. However, at a time when 
feelings of distress and anxiety are prominent, patients may be 
unable to attend to the depth of information being provided, 
limiting adherence to recommended disease-management 
strategies. For example, uncertainty regarding the provision of 
oxygen, both in terms of delivery and physical benefits, appears 
to be a major barrier to adherence.91 To ensure adherence, it is 
vital to follow up patients at home, at a time when feelings of 
distress are likely to have diminished and attention to informa-
tion may be improved. Furthermore, by repeating consistent 
health care messages and also providing written information, 
patients’ retention of knowledge may be enhanced. Seeing 
patients in their own environment allows for the tailoring of 
interventions and equipment according to any specific require-
ments and enables the involvement of family members in 
training. Positive social support has been noted to be influential 
in promoting compliance to both oxygen prescriptions and 
adherence to self-management strategies.58,93
Summary
Implementation of two or more components of the CCM has 
been shown to be effective in reducing health care utilization 
in patients with COPD.25 The role of self-management sup-
port following an AECOPD is especially important given the 
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current emphasis on reducing health care resource utilization. 
Disease management post-AE may be limited by  heightened 
levels of distress experienced by patients. Key factors 
likely to help promote adherence to nonpharmacological 
therapies include the timely assessment and management of 
 psychological symptoms, the delivery of respiratory-specific 
information, self-management skills from trained HCPs, and 
the sustained follow-up of patients after hospital discharge 
to reinforce health messages.
Areas for future research
Clinical management post-AECOPD should include 
 exploring the emotional as well as the clinical and physi-
ological impact of the exacerbation. It should also afford 
HCPs the time and knowledge to deliver respiratory-specific 
self-management skills to enhance adherence to nonpharma-
cological therapies.
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